ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,29355
-0,98%
Bitcoin
69.345,60
0,02%
Brent Oil
79,395
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Biodesix Inc (BDSX)

  7. Biodesix Inc (BDSX) Notícias

BDSX

Biodesix (BDSX)

Biodesix Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BDSX
DataHoraFonteTítuloCódigoCompanhia
05/06/202417:08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BDSXBiodesix Inc
05/06/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BDSXBiodesix Inc
28/05/202407:00Business WireBiodesix to Participate in Two Investor Conferences in JuneNASDAQ:BDSXBiodesix Inc
24/05/202417:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BDSXBiodesix Inc
23/05/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
23/05/202420:09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDSXBiodesix Inc
21/05/202407:00Business WireBiodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
09/05/202417:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
08/05/202417:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDSXBiodesix Inc
08/05/202417:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDSXBiodesix Inc
08/05/202417:01Business WireBiodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementNASDAQ:BDSXBiodesix Inc
07/05/202407:00Business WireBiodesix to Participate in the 2024 RBCCM Global Healthcare ConferenceNASDAQ:BDSXBiodesix Inc
24/04/202407:00Business WireBiodesix to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:BDSXBiodesix Inc
09/04/202418:00Business WireBiodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
05/04/202408:17Business WireBiodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private PlacementNASDAQ:BDSXBiodesix Inc
25/03/202407:00Business WireBiodesix Announces New Master Collaborative Research Agreement with Leading US Cancer CenterNASDAQ:BDSXBiodesix Inc
01/03/202408:11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BDSXBiodesix Inc
01/03/202408:00Business WireBiodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business HighlightsNASDAQ:BDSXBiodesix Inc
26/02/202408:00Business WireBiodesix to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDSXBiodesix Inc
16/02/202408:00Business WireBiodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024NASDAQ:BDSXBiodesix Inc
02/02/202418:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BDSXBiodesix Inc
14/11/202308:00Business WireBiodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw MethodNASDAQ:BDSXBiodesix Inc
09/11/202308:00Business WireBiodesix to Participate in Two Upcoming Investor Conferences in NovemberNASDAQ:BDSXBiodesix Inc
07/11/202318:01Business Wire Biodesix Announces Third Quarter 2023 Results and HighlightsNASDAQ:BDSXBiodesix Inc
24/10/202307:00Business WireBiodesix to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:BDSXBiodesix Inc
03/10/202307:00Business WireBiodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual MeetingNASDAQ:BDSXBiodesix Inc
07/09/202307:00Business WireBiodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung CancerNASDAQ:BDSXBiodesix Inc
05/09/202307:00Business WireBiodesix to Participate in Two Upcoming Investor Conferences in SeptemberNASDAQ:BDSXBiodesix Inc
22/08/202307:00Business WireBiodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing CancerNASDAQ:BDSXBiodesix Inc
07/08/202317:01Business WireBiodesix Announces Second Quarter 2023 Results and HighlightsNASDAQ:BDSXBiodesix Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BDSX

Seu Histórico Recente

BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
BOV
SGPS3
SPRINGS ON
BOV
SAPR4
SANEPAR PN
BOV
RPMG3
PET MANGUINH ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados